MLNT - Melinta Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts4465
Avg. Estimate-2.58-2.73-9.78-5.42
Low Estimate-2.89-3.07-11.07-7.62
High Estimate-2.29-2.35-6.1-3.02
Year Ago EPS-2.5-3.94-17.12-9.78
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts4465
Avg. Estimate17.06M19.53M68.17M102.62M
Low Estimate15M16.7M62M66M
High Estimate19.33M22.3M73M164.8M
Year Ago Sales34.08M35.49M96.43M68.17M
Sales Growth (year/est)-49.90%-45.00%-29.30%50.50%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-4.68-4.32-2.88-2.59
EPS Actual-2.5-3.94-2.34-3.07
Difference2.180.380.54-0.48
Surprise %46.60%8.80%18.80%-18.50%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-2.58-2.73-9.78-5.42
7 Days Ago-2.58-2.73-9.78-5.42
30 Days Ago-2.58-2.73-9.78-5.42
60 Days Ago-2.58-2.73-9.78-5.42
90 Days Ago-2.57-2.68-9.63-5.19
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesMLNTIndustrySectorS&P 500
Current Qtr.-3.20%N/AN/A-0.02
Next Qtr.30.70%N/AN/A0.07
Current Year42.90%N/AN/A-0.02
Next Year44.60%N/AN/A0.14
Next 5 Years (per annum)96.80%N/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A